RAD001 and ZOledronic acid in Renal cell carcinoma patients with bone metastases (RAZOR) – a randomised phase II trial

Files in this item

There are no files associated with this item.

Find Full text

This item appears in the following Collection(s)

Share

Search ResearchSpace


Browse

Statistics